Literature DB >> 8087949

Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area.

M Galli1, C Marcassa, R Bolli, P Giannuzzi, P L Temporelli, A Imparato, P L Silva Orrego, R Giubbini, A Giordano, L Tavazzi.   

Abstract

BACKGROUND: In patients with ventricular dysfunction caused by stunning or hibernation, it is not clear when complete recovery of the salvaged myocardium occurs after acute myocardial infarction. The purpose of this study was to determine whether a delayed recovery of perfusion and contraction continues even after the subacute phase. METHODS AND
RESULTS: We prospectively studied 71 consecutive male patients with first uncomplicated Q-wave anterior infarction. Resting regional blood flow distribution and contraction were assessed quantitatively 5 weeks and 7 months after the acute phase by serial sestamibi tomography and two-dimensional echocardiography. Coronary angiography also was performed in 52 patients. Overall, at 7 months there was an improvement in the perfusion defect severity (1019 +/- 811 versus 1365 +/- 821 at 5 weeks, P < .001) as well as in the extent of abnormal wall motion (28 +/- 19% versus 32 +/- 15%, P < .001) and left ventricular ejection fraction (53 +/- 14% versus 50 +/- 13%, P < .01). Among the 68 of 71 patients showing resting perfusion defects at 5 weeks, two groups were identified: 47 (group 1) who showed a significant (beyond the reproducibility limits) 7-month reduction of the resting perfusion defect, and 21 patients (group 2) in whom the perfusion defect remained unchanged. Ejection fraction and the extent of abnormal wall motion significantly (P < .01) improved in group 1 but not in group 2. Despite the presence of a comparable perfusion defect size between the two groups at 5 weeks after infarction, group 1 already showed a better regional and global ventricular function (P < .05). No significant differences were found between the two groups regarding age, medical therapy, the extent of underlying coronary disease, thrombolysis in the acute phase, Thrombolysis in Myocardial Infarction grade of the infarct-related vessel, and presence of collaterals on angiography.
CONCLUSIONS: After anterior Q-wave infarction, the recovery of perfusion and wall motion may continue well after the subacute phase. Several patients exhibit relative hypoperfusion in viable tissue as late as 5 weeks after infarction, and a significant improvement of perfusion in the infarcted area commonly is observed between 5 weeks and 7 months. This delayed improvement of perfusion is associated with a delayed improvement of contractile function in the infarcted area after the first 5 weeks, which may continue for up to 7 months, suggesting the presence of hibernating myocardium in the infarcted area. Despite similar perfusion defect sizes, the level of regional function can be different at 5 weeks, and measurements taken around this time may not accurately estimate the eventual recovery of function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087949     DOI: 10.1161/01.cir.90.3.1386

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery.

Authors:  M Faraggi; G Montalescot; L Sarda; J F Heintz; D Doumit; G Drobinski; I Sotirov; D Le Guludec; D Thomas
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 2.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

3.  Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery.

Authors:  D Czitrom; D Karila-Cohen; E Brochet; J M Juliard; M Faraggi; M C Aumont; P Assayag; P G Steg
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

4.  Tc-99m sestamibi infarct size as a surrogate endpoint.

Authors:  Raymond J Gibbons; Todd D Miller
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

5.  Time-course of dobutamine-induced wall motion abnormalities in the infarct area following thrombolytic therapy.

Authors:  R Bigi; G Curti; C Sponzilli; D Castini; G Occhi; C Fiorentini
Journal:  Int J Card Imaging       Date:  1998-12

6.  A cost-effective sestamibi protocol in the managed health care era.

Authors:  E Milan; R Giubbini; G Gioia; A Terzi; A E Iskandrian
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

7.  The role of early measurement of nitrogen-13 ammonia uptake for predicting contractile recovery after acute myocardial infarction.

Authors:  P Lancellotti; P G Mélon; C M de Landsheere; C Degueldre; H E Kulbertus; L A Piérard
Journal:  Int J Card Imaging       Date:  1998-08

8.  Assessment of myocardial viability in patients with acute myocardial infarction by two-dimensional speckle tracking echocardiography combined with low-dose dobutamine stress echocardiography.

Authors:  Lei Gong; Dongye Li; Junhong Chen; Xiaoping Wang; Tongda Xu; Wenhua Li; Shaoyang Ren; Cheng Wang
Journal:  Int J Cardiovasc Imaging       Date:  2013-01-29       Impact factor: 2.357

9.  The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits?

Authors:  Roberto Bolli; Buddhadeb Dawn
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

10.  Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study.

Authors:  Stefania Funaro; Giuseppe La Torre; Mariapina Madonna; Leonarda Galiuto; Antonio Scarà; Alessandra Labbadia; Emanuele Canali; Antonella Mattatelli; Francesco Fedele; Francesco Alessandrini; Filippo Crea; Luciano Agati
Journal:  Eur Heart J       Date:  2008-12-18       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.